![Eric Shaff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Shaff
Direktor/Vorstandsmitglied bei
SERES THERAPEUTICS, INC.
Vermögen: 88 133 $ am 31.05.2026
Profil
Eric D.
Shaff is President, Chief Executive Officer & Director at PsiThera, Inc. since 2025.
Mr. Shaff is Director at Seres Therapeutics, Inc. since 2014.
Former roles include Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023, Principal at Pfizer Inc., Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011, Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014, and Senior Analyst at Broadview International LLC.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Johnson Graduate School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 12’040 ( 0.12% ) | 88 133 $ | 31.05.2026 |
Aktive Positionen von Eric Shaff
| Unternehmen | Position | Beginn |
|---|---|---|
| SERES THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.01.2019 |
Ehemalige bekannte Positionen von Eric Shaff
| Unternehmen | Position | Ende |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.08.2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2014 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.12.2011 |
| PFIZER INC. | Corporate Officer/Principal | - |
Broadview International LLC
 Broadview International LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Ausbildung von Eric Shaff
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Broadview International LLC
Broadview International LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
